The Future of Disease Detection and Prevention

November 06, 2019|5:00pm

Andy Conrad, PhD, Chief Executive Officer of Verily Life Sciences?, will discuss the future of diagnostics/predictives with Russ Altman, MD, PhD, professor of bioengineering, medicine genetics, biomedical data science and (by courtesy) computer science.

Formerly the chief scientific officer of LabCorp, Conrad is a cell biologist with a doctorate from UCLA. He has always been passionate about early detection and prevention of disease. Andy co-founded the National Genetics Institute, which developed the first cost-effective test to screen for HIV in the blood supply.

Full event information: http://events.stanford.edu/events/854/85453

Admission Description:

RSVP for this event

Map URL: http://campus-map.stanford.edu/?id=07-515

Location: Li Ka Shing Center, LK130

Contact Email: jzuegel@stanford.edu

Contact Phone: 650-906-6099